HHLA2 is a newly discovered B7 family molecule, the interactions between B7 molecules and CD28-family receptors are crucial in cancer immunity, the aberrant expression of co-inhibitory B7 molecules has been attributed to reduced anti-tumor immunity and cancer immune evasion. Here, HHLA2 is linked to cancer.